A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase

Shu Fei Zhuang, Cai Hong Zhou, Jing Qian, Zhen Qian, Masabumi Shibuya, Qizhuang Ye

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

AIM: To establish a 96-well plate based kinase assay using a recombinant vascular endothelial growth factor (VEGF) receptor 1 kinase domain protein. METHODS: A human VEGF receptor 1 kinase domain protein was expressed in E coli, and its activity was monitored by its ability of phosphorylating the polyE4Y substrate coated on the walls of 96-well plates with antibody recognition and a colorimetric readout. A random screening of a sample organic compound library was carried out, and the hits were characterized with a transformed cell line stably expressing VEGF receptor 1 protein. RESULTS: An efficient E coli expression system for human VEGF receptor 1 kinase domain protein was constructed, and the purified recombinant protein was used to establish a practical screening assay for kinase inhibitors in vitro. Two thousand eight hundred organic compounds were screened, and two disubstituted furans (A1 and A5) with new structure showed inhibition of VEGF receptor 1 kinase. Compound A1 inhibited only phosphorylation of substrate, while compound A5 inhibited both autophosphorylation and substrate phosphorylation. Both inhibitors affected phosphorylation in the transformed cells. CONCLUSION: The recombinant receptor kinase based assay is simple and effective in identifying kinase inhibitors.

Original languageEnglish (US)
Pages (from-to)117-123
Number of pages7
JournalActa Pharmacologica Sinica
Volume23
Issue number2
StatePublished - 2002
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor Receptor-1
Screening
Phosphotransferases
Protein Kinases
Phosphorylation
Assays
Escherichia coli
Furans
Transformed Cell Line
Organic compounds
Proteins
Substrates
Recombinant Proteins
Libraries
Antibodies
Cells
Protein Domains

Keywords

  • Drug screening
  • Growth factor receptors
  • Protein-tyrosine kinase
  • Vascular endothelium

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmacology

Cite this

A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase. / Zhuang, Shu Fei; Zhou, Cai Hong; Qian, Jing; Qian, Zhen; Shibuya, Masabumi; Ye, Qizhuang.

In: Acta Pharmacologica Sinica, Vol. 23, No. 2, 2002, p. 117-123.

Research output: Contribution to journalArticle

Zhuang, SF, Zhou, CH, Qian, J, Qian, Z, Shibuya, M & Ye, Q 2002, 'A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase', Acta Pharmacologica Sinica, vol. 23, no. 2, pp. 117-123.
Zhuang, Shu Fei ; Zhou, Cai Hong ; Qian, Jing ; Qian, Zhen ; Shibuya, Masabumi ; Ye, Qizhuang. / A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase. In: Acta Pharmacologica Sinica. 2002 ; Vol. 23, No. 2. pp. 117-123.
@article{9efbc512f0c74fca96d3688d47a5d32c,
title = "A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase",
abstract = "AIM: To establish a 96-well plate based kinase assay using a recombinant vascular endothelial growth factor (VEGF) receptor 1 kinase domain protein. METHODS: A human VEGF receptor 1 kinase domain protein was expressed in E coli, and its activity was monitored by its ability of phosphorylating the polyE4Y substrate coated on the walls of 96-well plates with antibody recognition and a colorimetric readout. A random screening of a sample organic compound library was carried out, and the hits were characterized with a transformed cell line stably expressing VEGF receptor 1 protein. RESULTS: An efficient E coli expression system for human VEGF receptor 1 kinase domain protein was constructed, and the purified recombinant protein was used to establish a practical screening assay for kinase inhibitors in vitro. Two thousand eight hundred organic compounds were screened, and two disubstituted furans (A1 and A5) with new structure showed inhibition of VEGF receptor 1 kinase. Compound A1 inhibited only phosphorylation of substrate, while compound A5 inhibited both autophosphorylation and substrate phosphorylation. Both inhibitors affected phosphorylation in the transformed cells. CONCLUSION: The recombinant receptor kinase based assay is simple and effective in identifying kinase inhibitors.",
keywords = "Drug screening, Growth factor receptors, Protein-tyrosine kinase, Vascular endothelium",
author = "Zhuang, {Shu Fei} and Zhou, {Cai Hong} and Jing Qian and Zhen Qian and Masabumi Shibuya and Qizhuang Ye",
year = "2002",
language = "English (US)",
volume = "23",
pages = "117--123",
journal = "Zhongguo yao li xue bao = Acta pharmacologica Sinica",
issn = "1671-4083",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase

AU - Zhuang, Shu Fei

AU - Zhou, Cai Hong

AU - Qian, Jing

AU - Qian, Zhen

AU - Shibuya, Masabumi

AU - Ye, Qizhuang

PY - 2002

Y1 - 2002

N2 - AIM: To establish a 96-well plate based kinase assay using a recombinant vascular endothelial growth factor (VEGF) receptor 1 kinase domain protein. METHODS: A human VEGF receptor 1 kinase domain protein was expressed in E coli, and its activity was monitored by its ability of phosphorylating the polyE4Y substrate coated on the walls of 96-well plates with antibody recognition and a colorimetric readout. A random screening of a sample organic compound library was carried out, and the hits were characterized with a transformed cell line stably expressing VEGF receptor 1 protein. RESULTS: An efficient E coli expression system for human VEGF receptor 1 kinase domain protein was constructed, and the purified recombinant protein was used to establish a practical screening assay for kinase inhibitors in vitro. Two thousand eight hundred organic compounds were screened, and two disubstituted furans (A1 and A5) with new structure showed inhibition of VEGF receptor 1 kinase. Compound A1 inhibited only phosphorylation of substrate, while compound A5 inhibited both autophosphorylation and substrate phosphorylation. Both inhibitors affected phosphorylation in the transformed cells. CONCLUSION: The recombinant receptor kinase based assay is simple and effective in identifying kinase inhibitors.

AB - AIM: To establish a 96-well plate based kinase assay using a recombinant vascular endothelial growth factor (VEGF) receptor 1 kinase domain protein. METHODS: A human VEGF receptor 1 kinase domain protein was expressed in E coli, and its activity was monitored by its ability of phosphorylating the polyE4Y substrate coated on the walls of 96-well plates with antibody recognition and a colorimetric readout. A random screening of a sample organic compound library was carried out, and the hits were characterized with a transformed cell line stably expressing VEGF receptor 1 protein. RESULTS: An efficient E coli expression system for human VEGF receptor 1 kinase domain protein was constructed, and the purified recombinant protein was used to establish a practical screening assay for kinase inhibitors in vitro. Two thousand eight hundred organic compounds were screened, and two disubstituted furans (A1 and A5) with new structure showed inhibition of VEGF receptor 1 kinase. Compound A1 inhibited only phosphorylation of substrate, while compound A5 inhibited both autophosphorylation and substrate phosphorylation. Both inhibitors affected phosphorylation in the transformed cells. CONCLUSION: The recombinant receptor kinase based assay is simple and effective in identifying kinase inhibitors.

KW - Drug screening

KW - Growth factor receptors

KW - Protein-tyrosine kinase

KW - Vascular endothelium

UR - http://www.scopus.com/inward/record.url?scp=0036161020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036161020&partnerID=8YFLogxK

M3 - Article

C2 - 11866870

AN - SCOPUS:0036161020

VL - 23

SP - 117

EP - 123

JO - Zhongguo yao li xue bao = Acta pharmacologica Sinica

JF - Zhongguo yao li xue bao = Acta pharmacologica Sinica

SN - 1671-4083

IS - 2

ER -